The Influence of Acute Moderate-intensity Continuous Exercise on Appetite Regulation
1 other identifier
interventional
20
1 country
1
Brief Summary
A key area of obesity research has focused on the link between appetite, energy balance and weight control. Within this area, several appetite-related hormones and cellular cytokines have been identified as key signals influencing appetite and food intake. This includes the appetite-suppressing hormone oxyntomodulin (OXM) and a cellular stress-induced cytokine growth differentiation factor 15 (GDF-15). The aims of this study are: (1) to investigate the effect of acute moderate-intensity continuous exercise on oxyntomodulin and GDF-15 concentrations; (2) to investigate whether exercise-induced changes in circulating OXM and GDF-15 concentrations are correlated with subjective appetite perceptions and subsequent energy intake.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable obesity
Started Jun 2023
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 7, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 7, 2023
CompletedFirst Submitted
Initial submission to the registry
February 29, 2024
CompletedFirst Posted
Study publicly available on registry
March 6, 2024
CompletedMarch 6, 2024
February 1, 2024
5 months
February 29, 2024
February 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Oxyntomodulin
(pmol/L)
Blood samples were collected for oxyntomodulin measurements at 0 (baseline), 60, 90, 120, 150, 180, 210 minutes in each trial.
Growth Differentiation Factor 15
(pg/mL)
Blood samples were collected for GDF-15 measurements at 0 (baseline), 60, 90, 120, 150, 180, 210 minutes in each trial.
Secondary Outcomes (2)
Visual analogue score (VAS) for subjective appetite
VAS was measured at 0 (baseline), 60, 90, 120, 150, 180, 210 minutes in each trial.
Energy intake
Ad libitum pasta meal provided at 120 minutes.
Study Arms (2)
Exercise
EXPERIMENTALParticipants were asked to arrive at the lab at 8.30 am, having fasted overnight for 10 hours. After resting in the lab for 30 minutes, participants were asked to exercise at an intensity of 70 percent of their peak oxygen uptake for an hour before resting in the lab for a further 2.5 hours. Ad libitum energy intake was assessed 1 h after exercise completion.
Control
NO INTERVENTIONParticipants replicated all the procedures of the exercise trial except they rested for 1 h as the exercise counterpart.
Interventions
Eligibility Criteria
You may qualify if:
- Body mass index between 18.5-24.9 kg/m²;
- Habitually consume three meals a day;
- Able to run continuously for 1 hour;
- Not currently dieting and weight stable for 3 months (\< 3 kg change in weight);
- No severe dislike or allergy to any of the study food;
- Regular menstrual cycle in the past 6 months.
You may not qualify if:
- Smokers (vaping is considered smoking in this study);
- Individuals with medical conditions (e.g., diabetes, heart condition);
- Individuals taking medications that may influence the study outcomes;
- Individuals with clinically diagnosed eating disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Loughborough University
Loughborough, LE11 3TU, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David J Stensel
Loughborough University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 29, 2024
First Posted
March 6, 2024
Study Start
June 23, 2023
Primary Completion
November 7, 2023
Study Completion
November 7, 2023
Last Updated
March 6, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will share
Anonymised data will be made available to researchers upon request.